Credit: UAB News
Alan Tita, M.D., Ph.D., professor of Obstetrics and Gynecology in UAB's School of Medicine, says preeclampsia presents serious implications for mother and baby. "The hope is that ATryn will be a substantial advance in the treatment of preeclampsia and significantly improve outcomes for mother and baby."